RecruitingNCT05935709

DANIsh VASculitis Database (DANIVAS)

Disease Stratification in GCA and PMR to Inform Management and Reduce Disease and Treatment-related Damage


Sponsor

Aarhus University Hospital

Enrollment

3,000 participants

Start Date

Nov 10, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this national pragmatic observational study is to investigate whether the use of new diagnostic imaging modalities facilitates disease stratification that can potentially predict treatment response, relapse risk and complications and hence guide management strategies to improve disease control and reduce disease and treatment related damage.


Eligibility

Min Age: 50 Years

Inclusion Criteria4

  • Are diagnosed with GCA or PMR within the last 5 years
  • Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion)
  • Speak and understand Danish
  • Are able to give signed and dated informed consent

Exclusion Criteria2

  • Denies or are not able to give informed consent
  • Are diagnosed with other systemic autoimmune diseases that out-rules the diagnosis of GCA or PMR

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Led og Bindevævssygdomme, Aarhus University Hospital

Aarhus, Denmark

Medicinsk klinik 2, Regionshospitalet Horsens

Horsens, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05935709


Related Trials